✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Piramal Pharma Ltd.

PPLPHARMA

Market Cap
₹29,650 Cr.
P/E
762.22

Piramal Pharma Ltd.

  • Piramal Pharma
  • Suven Pharma
  • Hikal
FAQs on Piramal Pharma Ltd. Shareprice

Piramal Pharma has given better returns compared to its competitors.
Piramal Pharma has grown at ~78.77% over the last 2yrs while peers have grown at a median rate of 19.07%

Yes, Piramal Pharma is expensive.
Latest PE of Piramal Pharma is 762, while 3 year average PE is 183.
Also latest EV/EBITDA of Piramal Pharma is 23.97 while 3yr average is 23.91.

View FAQ's On Business
Growth Table
  • Piramal Pharma Ltd.
  • Suven Pharma
  • Hikal
Balance Sheet
  • Piramal Pharma Ltd.
  • Suven Pharma
  • Hikal
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Piramal Pharma Ltd.
  • Suven Pharma
  • Hikal
Cash Flow
  • Piramal Pharma Ltd.
  • Suven Pharma
  • Hikal
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Piramal Pharma Ltd.
  • Suven Pharma
  • Hikal
Quarterly Results
  • Piramal Pharma Ltd.
  • Suven Pharma
  • Hikal
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Piramal Pharma Ltd. Financials

Balance sheet of Piramal Pharma is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Piramal Pharma is increasing.
Latest debt of Piramal Pharma is ₹4,245 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹3,617 Crs.

The profit is oscillating.
The profit of Piramal Pharma is -₹29.85 Crs for TTM, ₹17.82 Crs for Mar 2024 and -₹186.46 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Piramal Pharma latest dividend payout ratio is 81.66% and 3yr average dividend payout ratio is 81.66%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech